Viewing Study NCT02721966


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2026-02-28 @ 12:18 AM
Study NCT ID: NCT02721966
Status: COMPLETED
Last Update Posted: 2020-10-01
First Post: 2016-03-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CAIN457F3302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators